300 related articles for article (PubMed ID: 10524564)
21. Treatment of Graves' hyperthyroidism with radioiodine: results of a prospective randomized study.
Peters H; Fischer C; Bogner U; Reiners C; Schleusener H
Thyroid; 1997 Apr; 7(2):247-51. PubMed ID: 9133695
[TBL] [Abstract][Full Text] [Related]
22. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.
Sabri O; Zimny M; Schulz G; Schreckenberger M; Reinartz P; Willmes K; Buell U
J Clin Endocrinol Metab; 1999 Apr; 84(4):1229-33. PubMed ID: 10199759
[TBL] [Abstract][Full Text] [Related]
23. Personalization of radioiodine treatment for Graves' disease: a prospective, randomized study with a novel method for calculating the optimal 131I-iodide activity based on target reduction of thyroid mass.
Orsini F; Traino AC; Grosso M; Guidoccio F; Boni G; Volterrani D; Mariani G
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):496-502. PubMed ID: 23358401
[TBL] [Abstract][Full Text] [Related]
24. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while?
Jarløv AE; Hegedüs L; Kristensen LO; Nygaard B; Hansen JM
Clin Endocrinol (Oxf); 1995 Sep; 43(3):325-9. PubMed ID: 7586602
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
26. Outcome of 131I therapy in hyperthyroidism using a 550MBq fixed dose regimen.
Lewis A; Atkinson B; Bell P; Courtney H; McCance D; Mullan K; Hunter S
Ulster Med J; 2013 May; 82(2):85-8. PubMed ID: 24082285
[TBL] [Abstract][Full Text] [Related]
27. Radioiodine (131I) therapy of Graves' disease: use of the new high resolutional ultrasonic scanner for the determination of the accurate weight of the thyroid gland.
Nagayama Y; Ashizawa K; Matsuo K; Inoue S; Harakawa S; Hirayu H; Yamashita S; Izumi M; Nagataki S
Endocrinol Jpn; 1989 Jun; 36(3):359-65. PubMed ID: 2684619
[TBL] [Abstract][Full Text] [Related]
28. A randomized comparison of radioiodine doses in Graves' hyperthyroidism.
Leslie WD; Ward L; Salamon EA; Ludwig S; Rowe RC; Cowden EA
J Clin Endocrinol Metab; 2003 Mar; 88(3):978-83. PubMed ID: 12629071
[TBL] [Abstract][Full Text] [Related]
29. Ultrasonographic thyroid volume as a reliable prognostic index of radioiodine-131 treatment outcome in Graves' disease hyperthyroidism.
Gómez-Arnaiz N; Andía E; Gumà A; Abós R; Soler J; Gómez JM
Horm Metab Res; 2003 Aug; 35(8):492-7. PubMed ID: 12953167
[TBL] [Abstract][Full Text] [Related]
30. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
Andrade VA; Gross JL; Maia AL
J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
[TBL] [Abstract][Full Text] [Related]
31. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
33. Iodine prophylaxis intensification. Influence on radioiodine uptake and activity of 131I used in the treatment of hyperthyroid patients with Graves' disease.
Baczyk M; Junik R; Ziemnicka K; Sowiński J
Nuklearmedizin; 2005; 44(5):197-9. PubMed ID: 16395495
[TBL] [Abstract][Full Text] [Related]
34. [The outcome of treatment with adjusted dose of 131I to thyroid weight for Graves' disease by estimation of effective half life using a single radioiodine uptake measurement].
Gomi Y; Watanabe M; Yoshimura H; Ishikawa N; Momotani N; Ito K; Inoue T; Ito K; Suzuki S
Kaku Igaku; 2000 Mar; 37(2):109-14. PubMed ID: 10783569
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors of failure in a fixed 15 mCi 131I-iodide therapy for Graves' disease.
Moura-Neto A; Mosci C; Santos AO; Amorim BJ; de Lima MC; Etchebehere EC; Tambascia MA; Ramos CD; Zantut-Wittmann DE
Clin Nucl Med; 2012 Jun; 37(6):550-4. PubMed ID: 22614185
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic 131I dose in hyperthyroidism: role of pretreatment with thionamide.
Kabadi U; Cech R
Thyroidology; 1994 Dec; 6(3):87-92. PubMed ID: 7545000
[TBL] [Abstract][Full Text] [Related]
37. Radioiodine therapy of hyperfunctioning thyroid nodules: usefulness of an implemented dose calculation algorithm allowing reduction of radioiodine amount.
Schiavo M; Bagnara MC; Pomposelli E; Altrinetti V; Calamia I; Camerieri L; Giusti M; Pesce G; Reitano C; Bagnasco M; Caputo M
Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):301-7. PubMed ID: 23486350
[TBL] [Abstract][Full Text] [Related]
38. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
Reinhardt MJ; Brink I; Joe AY; Von Mallek D; Ezziddin S; Palmedo H; Krause TM
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
[TBL] [Abstract][Full Text] [Related]
39. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
[TBL] [Abstract][Full Text] [Related]
40. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]